Abstract |
The relative failure of symptomatic therapeutic trials for Alzheimer's disease using non-selective cholinergic agonists brings about the need for longitudinal studies with parallel designs aimed at disease stabilization, using trophic substances or amyloid suppressors.
|
Authors | S Gauthier, L Gauthier, R Bouchard, R Quirion, S Sultan |
Journal | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
(Can J Neurol Sci)
Vol. 18
Issue 3 Suppl
Pg. 439-41
(Aug 1991)
ISSN: 0317-1671 [Print] England |
PMID | 1933695
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
|
Topics |
- Alzheimer Disease
(drug therapy, psychology)
- Clinical Trials as Topic
(methods)
- Humans
- Parasympathomimetics
(therapeutic use)
- Prognosis
- Psychiatric Status Rating Scales
- Research Design
- Treatment Outcome
|